A new study on the effects of acute kidney injury in military personnel who are injured during combat in Iraq and Afghanistan reveals better-than-expected results concerning survival and kidney function.
Researchers from the Walter Reed National Military Medical Center analyzed the medical records of 51 military members who were evacuated and treated for the condition. Patients were followed for a median of just over three years. Their findings were published in the Clinical Journal of the American Society Nephrology (CJASN).
The investigators found that 88% of the injuries were due to blasts or projectiles. Twenty-two percent of the patients died within 60 days, which is significantly less than expected: the lower range of mortality in historical reports for military casualties with severe AKI, and the reported average in recent civilian studies are both approximately 50%.
In this study, of the 40 survivors, one developed end-stage renal failure, ome was diagnosed with stage 2 chronic kidney disease, and 36 regained normal kidney function but developed proteinuria (excess excretion of protein in the urine).
“It is reasonable to assume that the cases reported were similarly injured to those in the Vietnam and Korean wars, and yet the outcomes are very significantly better,” said Jorge Cerdá, MD, FACP, FASN, who was not involved with the study. “Although the reason for the better outcomes cannot be established for sure, it is likely that earlier evacuation from the field, very aggressive resuscitation, and multiple surgical interventions made the difference in permitting survival of those with dialysis-requiring AKI,” added Dr. Cerdá, who is a Clinical Professor of Medicine in Albany Medical College’s Division of Nephrology and a member of ASN’s AKI Advisory Group. He noted that although most survivors normalized their kidney function, the presence of proteinuria is concerning for permanent and possibly progressive injury, which warrants life-long follow up.
Study authors include Jonathan Bolanos, MD, Christina Yuan, MD, Dustin Little, David
Oliver, RN, Steven Howard, BA, Kevin Abbott, MD, MPH, and Stephen Olson, MD.